Search Results

There are 4869 results for: content related to: New therapeutic strategies in HCV: polymerase inhibitors

  1. You have free access to this content
    Optimal therapy in genotype 4 chronic hepatitis C: finally cured?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 27–34, Wael Abdel-Razek and Imam Waked

    Article first published online : 22 DEC 2014, DOI: 10.1111/liv.12724

  2. Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series

    Liver International

    Tavankit Singh, John Guirguis, Sumi Anthony, John Rivas, Ibrahim A. Hanouneh and Naim Alkhouri

    Article first published online : 22 FEB 2016, DOI: 10.1111/liv.13078

  3. You have free access to this content
    HCV direct-acting antiviral agents: the best interferon-free combinations

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 69–78, Raymond Schinazi, Philippe Halfon, Patrick Marcellin and Tarik Asselah

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12423

  4. You have free access to this content
    Treatment of hepatitis C virus genotype 3-infection

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 18–23, Stanislas Pol, Anaïs Vallet-Pichard and Marion Corouge

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12405

  5. You have free access to this content
    Best strategies for global HCV eradication

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 68–79, Liesl M. Hagan and Raymond F. Schinazi

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12063

  6. You have free access to this content
    Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy

    Liver International

    Volume 35, Issue 8, August 2015, Pages: 1923–1933, Saeed H. Al Marzooqi and Jordan J. Feld

    Article first published online : 3 JUN 2015, DOI: 10.1111/liv.12861

  7. You have free access to this content
    Optimal therapy of genotype-2 chronic hepatitis C: what's new?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 21–26, Marc Bourlière, Souad Benali, Christelle Ansaldi, Gaelle Le Folgoc, Aurelie Riso and Laurence Lecomte

    Article first published online : 22 DEC 2014, DOI: 10.1111/liv.12711

  8. Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES

    Liver International

    Volume 36, Issue 5, May 2016, Pages: 651–658, Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Raymond T. Chung, Kenneth E. Sherman and For the ERCHIVES study

    Article first published online : 25 DEC 2015, DOI: 10.1111/liv.13036

  9. You have full text access to this OnlineOpen article
    A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection

    Liver International

    Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, Cheng-Yuan Peng, Tsung-Hui Hu, Gin-Ho Lo, Horng-Yuan Wang, Jyh-Jou Chen, Jenny C. Yang, Steven J. Knox, Lingling Han, Hongmei Mo, Anita Mathias, Diana M. Brainard, I-Shyan Sheen, Yu-Chun Hsu, Chi-Jen Chu and Wan-Long Chuang

    Article first published online : 23 MAR 2016, DOI: 10.1111/liv.13082

  10. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients

    Liver International

    Volume 35, Issue 11, November 2015, Pages: 2442–2447, Sammy Saab, Adam Greenberg, Edwin Li, Sherona Ngashea Bau, Francisco Durazo, Mohammed El-Kabany, Steven Han and Ronald W. Busuttil

    Article first published online : 12 MAY 2015, DOI: 10.1111/liv.12856

  11. Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

    Liver International

    Volume 35, Issue 7, July 2015, Pages: 1845–1852, Christoph Höner zu Siederdissen, Benjamin Maasoumy, Katja Deterding, Kerstin Port, Lisa Sollik, Carola Mix, Janina Kirschner, Janet Cornberg, Michael P. Manns, Heiner Wedemeyer and Markus Cornberg

    Article first published online : 2 FEB 2015, DOI: 10.1111/liv.12774

  12. You have free access to this content
    Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 56–64, Tarik Asselah and Patrick Marcellin

    Article first published online : 22 DEC 2014, DOI: 10.1111/liv.12745

  13. Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 1–4, Maria Francesca Donato, Sara Monico, Federica Malinverno, Alessio Aghemo, Marco Maggioni, Paolo Reggiani and Massimo Colombo

    Article first published online : 16 AUG 2014, DOI: 10.1111/liv.12646

  14. You have full text access to this OnlineOpen article
    HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape

    Liver International

    Volume 36, Issue 4, April 2016, Pages: 488–502, Nancy Reau, Michael W. Fried, David R. Nelson, Robert S. Brown Jr, Gregory T. Everson, Stuart C. Gordon, Ira M. Jacobson, Joseph K. Lim, Paul J. Pockros, K. Rajender Reddy and Kenneth E. Sherman

    Article first published online : 22 NOV 2015, DOI: 10.1111/liv.12993

  15. You have free access to this content
    Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 105–110, Mitchell L. Shiffman and Yves Benhamou

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12066

  16. You have free access to this content
    Pegylated interferon based therapy with second-wave direct-acting antivirals in genotype 1 chronic hepatitis C

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 11–17, Nicole M. Welch and Donald M. Jensen

    Article first published online : 22 DEC 2014, DOI: 10.1111/liv.12715

  17. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 120–129, Raffaele Bruno, Giuseppe Cariti, Paola Nasta, Amedeo Capetti, Veronica Ravasio, Massimo Galli, Enzo Raise, Giulio Palmieri, Claudio Iannacone and Massimo Puoti

    Article first published online : 11 AUG 2014, DOI: 10.1111/liv.12641

  18. You have free access to this content
    Interferon free therapy with direct acting antivirals for HCV

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 93–104, Tarik Asselah and Patrick Marcellin

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12076

  19. You have free access to this content
    Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 60–68, Tarik Asselah and Patrick Marcellin

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12424

  20. You have free access to this content
    Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

    Liver International

    Volume 36, Issue S1, January 2016, Pages: 47–57, Tarik Asselah, Nathalie Boyer, David Saadoun, Michele Martinot-Peignoux and Patrick Marcellin

    Article first published online : 4 JAN 2016, DOI: 10.1111/liv.13027